| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | IXICO plc - Scientific advisors & partners update | - | RNS | ||
| 22.05. | IXICO plc - Company presentation at Mello 2026 | 1 | RNS | ||
| 21.05. | IXICO plc - Contract win and contract extension | 1 | RNS | ||
| IXICO Aktie jetzt für 0€ handeln | |||||
| 19.05. | AIM Market Roundup: Novacyt, Ixico, Pennant | 3 | The Armchair Trader | ||
| 19.05. | IN BRIEF: Ixico reaffirms growth guidance as half-year revenue rises | 2 | Alliance News | ||
| 19.05. | Ixico reports higher interim revenue, larger order book | 2 | Sharecast | ||
| 19.05. | IXICO plc - Interim results for six months ending 31/03/2026 | 1 | RNS | ||
| 12.05. | IXICO plc - IXICO Updates AI Neuroimaging Platform | 4 | RNS | ||
| 27.04. | IXICO plc - Holding(s) in Company | 9 | RNS | ||
| 24.04. | IXICO plc - Holding(s) in Company | 6 | RNS | ||
| 22.04. | IXICO plc - Issue of Equity | 7 | RNS | ||
| 21.04. | IXICO plc - Trading Update | 7 | RNS | ||
| 16.04. | IXICO plc - Result of GM and Update on Issue of Equity | 7 | RNS | ||
| 31.03. | EARNINGS AND TRADING: Future takes "cautious view"; Ixico's fundraise | 11 | Alliance News | ||
| 31.03. | IXICO plc - Retail Offer | 10 | RNS | ||
| 31.03. | IXICO plc - Placings and Subscription | 10 | RNS | ||
| 26.03. | IXICO plc - Collaboration with Medidata | 10 | RNS | ||
| 26.02. | IXICO validates automated brain imaging analysis platform | 16 | Investing.com | ||
| 26.02. | IXICO: Automatisierte Analyseplattform für Gehirnbilder übertrifft manuelle Verfahren | 16 | Investing.com Deutsch | ||
| 26.02. | IXICO plc - Validation of Neuroimaging Technology Platform | 15 | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 35,790 | -1,39 % | Eli Lillys neues Abnehmmittel könnte Ozempic alt aussehen lassen | Eli Lilly hat auf dem größten Diabeteskongress der Welt Daten präsentiert, die die Adipositas-Pipeline des Konzerns in einem völlig neuen Licht erscheinen lassen. Auf dem Jahreskongress der American... ► Artikel lesen | |
| AURORA CANNABIS | 2,934 | -2,40 % | Aurora Deepens its Impact for Veterans Across Canada | ||
| CANOPY GROWTH | 0,900 | +0,69 % | Canopy Growth Just Made a Big Acquisition: Game-Changer -- or Another Misstep? | ||
| TILRAY BRANDS | 4,535 | +1,45 % | A Major Milestone for the Cannabis Industry Is Coming, and Why It's Bad News for Tilray Brands | ||
| VERTEX PHARMACEUTICALS | 384,25 | -0,49 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on ALYFTREK at European Cystic Fibrosis Conference | - ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels... ► Artikel lesen | |
| MPH HEALTH CARE | 27,900 | -1,76 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
05.06.2026 / 12:45 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| CRONOS GROUP | 2,380 | -1,73 % | Cronos Group Inc.: Cronos Group Reports 2026 First Quarter Results | Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter... ► Artikel lesen | |
| SYNBIOTIC | 1,570 | -3,68 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr 2026 | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Prognose
SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr... ► Artikel lesen | |
| DIGICANN VENTURES | 0,002 | +300,00 % | XFRA VY3: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDIGICANN VENTURES... ► Artikel lesen | |
| EYEPOINT | 10,100 | 0,00 % | EyePoint, Inc.: EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU, Building Confidence Ahead of Mid-2026 Topline Data | - LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after - - Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,900 | -4,26 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 7,370 | -1,47 % | Green Thumb Industries Reports First Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,239 | -1,74 % | 1CM Inc.: 1CM Provides Update on Arrangement Agreement with SNDL | Toronto, Ontario--(Newsfile Corp. - May 27, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announces that it does not expect the proposed sale of its Ontario retail locations to... ► Artikel lesen | |
| SINOPHARM | 1,872 | 0,00 % | Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou | 860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 1,450 | -21,20 % | Noveris Health Sciences Inc: Noveris Health appoints Griffiths as strategic adviser |